Filing Overview
Registrant: Rotor Acquisition Corp. (the filing text does not identify Palladyne AI Corp.); Form: 8-K; report date: September 15, 2021, with the filing signed September 16, 2021. The filing reports the results of a special meeting of stockholders held in connection with the proposed business combination with Sarcos Corp.
Business Context and Reporting Period
Rotor Acquisition Corp. proposed combining with Sarcos Corp. through a merger of Rotor Merger Sub Corp. with and into Sarcos, with Sarcos surviving as a wholly owned subsidiary. The filing covers stockholder voting at the September 15, 2021 special meeting and related Regulation FD disclosure.
As of the August 2, 2021 record date, approximately 27.6 million Class A shares and 6.9 million Class B shares were outstanding. Approximately 26.96 million shares, or 78.136% of voting shares entitled to vote, were present in person or by proxy, establishing a quorum. No broker non-votes were reported.
Financial and Capital Metrics
- The filing does not provide revenue, profit, cash flow, operating margins, debt, cash balances, liquidity measures, or financial guidance.
- The company’s registered securities were units, Class A common stock, and redeemable warrants listed on the NYSE under ROT.U, ROT, and ROT WS, respectively.
- The filing states that the NYSE proposal would authorize issuance of more than 20% of the company’s issued and outstanding Class A common stock in connection with the business combination, but it does not state the proposed number of shares or transaction valuation.
Voting Results and Material Changes
| Proposal | For | Against | Abstentions | Result |
|---|---|---|---|---|
| Business combination | 26,295,974 | 592,783 | 68,085 | Approved |
| NYSE share issuance | 26,293,868 | 593,485 | 69,489 | Approved |
| Proposed charter | 26,294,881 | 592,775 | 69,186 | Approved |
| Increase authorized stock | 23,322,465 | 3,336,739 | 297,638 | Approved |
| Supermajority charter amendment requirement | 24,330,454 | 2,328,498 | 297,890 | Approved |
| Director removal provisions | 23,106,017 | 3,555,384 | 295,441 | Approved |
| Elimination of written-consent rights | 23,559,093 | 3,096,907 | 300,482 | Approved |
| Equity incentive plan | 24,765,766 | 2,115,689 | 75,387 | Approved |
| Employee stock purchase plan | 26,278,588 | 609,675 | 68,579 | Approved |
The eight proposed directors were elected with 6,109,616 votes for and no votes withheld for each nominee: Benjamin G. Wolff, Brian D. Finn, Peter Klein, Laura J. Peterson, Eric T. Olson, Dennis Weibling, Matthew Shigenobu Muta, and Priya Balasubramaniam.
Because sufficient votes were available to approve all proposals, the adjournment proposal was not applicable. Approval of the proposals did not itself provide a reported closing date for the business combination.
Outlook, Risks, and Unusual Items
- The principal transaction contingency was completion of the proposed merger with Sarcos and the related transactions described in the merger agreement.
- The NYSE issuance approval, charter amendments, authorized-share increase, equity incentive plan, and employee stock purchase plan may affect future capitalization, governance, dilution, and stockholder rights.
- The filing provides no updated operating outlook, financial forecast, liquidity assessment, or discussion of transaction financing.
- The company identified itself as an emerging growth company and had elected to use the extended transition period for complying with new or revised accounting standards.
Investor Verification Checklist
- Verify the registrant identity: the source filing is for Rotor Acquisition Corp., while the request metadata names Palladyne AI Corp.
- Confirm whether and when the Sarcos business combination subsequently closed, including the final legal name, ticker, capitalization, and exchange listing.
- Review the merger agreement and proxy statement for transaction consideration, share issuance, redemption terms, warrants, financing, and dilution.
- Assess the final charter, governance structure, authorized share count, supermajority provisions, and limits on stockholder action by written consent.
- Review the approved equity incentive plan and ESPP for share reserves and potential dilution.